Shares of Third Wave Technologies fell nearly 10 percent for the five-day trading week ended Tuesday. The only news to come from the firm was last week’s announcement that its Japanese subsidiary had raised roughly $5.3 million in a Series A financing. The stock led all decliners in the BCW Index for the week.
 
Bruker BioSciences' stock rose 5 percent, leading the six stocks that gained value during the tracking period.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.